ArticleMolecular biology reports2025
Endoplasmic reticulum stress pathways and cellular death mechanisms in patients with phenylketonuria.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of an extraction protocol from dried blood spots for untargeted metabolomics: application to phenylketonuria.Metabolomics : Official journal of the Metabolomic Society · 2025Article
- Metabolomics and Lipidomics Explore Phenotype-Specific Molecular Signatures for Phenylketonuria.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPhenylketonuria (PKU) is an inherited metabolic disease of amino acid metabolism characterized by the deficiency of activity in phenylalanine (Phe) hydroxylase enzyme, leading to the accumulation of Phe and its metabolites in the blood and tissues of affected patients. PKU, caused by various mutations leading to misfolded or nonfunctional proteins in the cells, still has an incompletely understood pathophysiology. This study aims to investigate the role of endoplasmic reticulum (ER) stress and ER stress response in PKU pathophysiology. METHODS AND
resultsPeripheral blood mononuclear cells (PBMCs) isolated from PKU patients carrying distinct protein misfolding mutations were analyzed to investigate the involvement of ER stress-related gene expression and cell death pathways. A comprehensive evaluation was conducted using quantitative real-time PCR and flow cytometry under both physiological (basal) conditions and following Phe administration, with the aim of elucidating the molecular mechanisms underlying Phe-induced cellular stress. Our results demonstrates that PKU patients exhibit a response to ER stress mediated by the IRE1 and ATF6 pathways of the UPR. We also observe disruptions in autophagic flux, as shown by the expression results of LC3B and p62 proteins. Importantly, the PBMCs do not appear to undergo immediate apoptotic cell death. The avoidance of apoptosis induction, even in the context of acute Phe treatment in the PBMCs of PKU patients who have been chronically exposed to ER stress, indicates an adaptive mechanism that facilitates cellular survival in these patients.
conclusionsBy focusing on the ER stress response in PKU patients with different type of mutations leading to protein misfolding, this study has the potential to provide new insights into PKU pathophysiology.
Indexed as
Identifiers
40522434What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.